Search research articles
Contact Us
Filters
Showing results (131-140 of 165) with videos related to
Page
of 17
Sort By:
Leukemia & Lymphoma
|
January 2, 2024
High-dose chemotherapy and autologous stem cell transplant as first salvage treatment for relapsed or refractory Hodgkin Lymphoma in the era of PET-adapted strategies
Simonetta Viviani, Anna Vanazzi, Samuele Frassoni, et al.
Journal of Translational Medicine
|
January 14, 2025
Lactate accumulation promotes immunosuppression and fibrotic transformation of bone marrow microenvironment in myelofibrosis
Mariarita Spampinato, Cesarina Giallongo, Sebastiano Giallongo, et al.
The Lancet. Healthy Longevity
|
September 14, 2022
Association of IMWG frailty score with health-related quality of life profile of patients with relapsed refractory multiple myeloma in Italy and the UK: a GIMEMA, multicentre, cross-sectional study
Fabio Efficace, Gianluca Gaidano, Maria Teresa Petrucci, et al.
Hematological Oncology
|
July 1, 2020
Early serum TARC reduction predicts prognosis in advanced-stage Hodgkin lymphoma patients treated with a PET-adapted strategy
Simonetta Viviani, Arabella Mazzocchi, Chiara Pavoni, et al.
Blood
|
January 14, 2011
Complete response correlates with long-term progression-free and overall survival in elderly myeloma treated with novel agents: analysis of 1175 patients
Francesca Gay, Alessandra Larocca, Pierre Wijermans, et al.
Oncogenesis
|
January 22, 2022
CXCL12/CXCR4 axis supports mitochondrial trafficking in tumor myeloma microenvironment
Cesarina Giallongo, Ilaria Dulcamare, Daniele Tibullo, et al.
International Journal of Molecular Sciences
|
June 12, 2026
Coevolution of NK and Tumor Cell States Along Multiple Myeloma Progression from Precursor Conditions
Cristina Aquilina, Andrea Romano, Anna Maria Corsale, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 18, 2020
Consolidation Radiotherapy Could Be Safely Omitted in Advanced Hodgkin Lymphoma With Large Nodal Mass in Complete Metabolic Response After ABVD: Final Analysis of the Randomized GITIL/FIL HD0607 Trial
Andrea Gallamini, Andrea Rossi, Caterina Patti, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 30, 2021
Development and Validation of a Simplified Score to Predict Early Relapse in Newly Diagnosed Multiple Myeloma in a Pooled Dataset of 2,190 Patients
Gian Maria Zaccaria, Luca Bertamini, Maria Teresa Petrucci, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 7, 2025
Targeting Acetyl-CoA Carboxylase Suppresses De Novo Lipogenesis and Tumor Cell Growth in Multiple Myeloma
Eugenio Morelli, Caroline Fidalgo Ribeiro, Silvia D Rodrigues, et al.
Page
of 17
Search research articles
Search
Showing results (131-140 of 165) with videos related to
Sort By:
Page
of 17
Leukemia & Lymphoma
|
January 2, 2024
High-dose chemotherapy and autologous stem cell transplant as first salvage treatment for relapsed or refractory Hodgkin Lymphoma in the era of PET-adapted strategies
Simonetta Viviani, Anna Vanazzi, Samuele Frassoni, et al.
Journal of Translational Medicine
|
January 14, 2025
Lactate accumulation promotes immunosuppression and fibrotic transformation of bone marrow microenvironment in myelofibrosis
Mariarita Spampinato, Cesarina Giallongo, Sebastiano Giallongo, et al.
The Lancet. Healthy Longevity
|
September 14, 2022
Association of IMWG frailty score with health-related quality of life profile of patients with relapsed refractory multiple myeloma in Italy and the UK: a GIMEMA, multicentre, cross-sectional study
Fabio Efficace, Gianluca Gaidano, Maria Teresa Petrucci, et al.
Hematological Oncology
|
July 1, 2020
Early serum TARC reduction predicts prognosis in advanced-stage Hodgkin lymphoma patients treated with a PET-adapted strategy
Simonetta Viviani, Arabella Mazzocchi, Chiara Pavoni, et al.
Blood
|
January 14, 2011
Complete response correlates with long-term progression-free and overall survival in elderly myeloma treated with novel agents: analysis of 1175 patients
Francesca Gay, Alessandra Larocca, Pierre Wijermans, et al.
Oncogenesis
|
January 22, 2022
CXCL12/CXCR4 axis supports mitochondrial trafficking in tumor myeloma microenvironment
Cesarina Giallongo, Ilaria Dulcamare, Daniele Tibullo, et al.
International Journal of Molecular Sciences
|
June 12, 2026
Coevolution of NK and Tumor Cell States Along Multiple Myeloma Progression from Precursor Conditions
Cristina Aquilina, Andrea Romano, Anna Maria Corsale, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 18, 2020
Consolidation Radiotherapy Could Be Safely Omitted in Advanced Hodgkin Lymphoma With Large Nodal Mass in Complete Metabolic Response After ABVD: Final Analysis of the Randomized GITIL/FIL HD0607 Trial
Andrea Gallamini, Andrea Rossi, Caterina Patti, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 30, 2021
Development and Validation of a Simplified Score to Predict Early Relapse in Newly Diagnosed Multiple Myeloma in a Pooled Dataset of 2,190 Patients
Gian Maria Zaccaria, Luca Bertamini, Maria Teresa Petrucci, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 7, 2025
Targeting Acetyl-CoA Carboxylase Suppresses De Novo Lipogenesis and Tumor Cell Growth in Multiple Myeloma
Eugenio Morelli, Caroline Fidalgo Ribeiro, Silvia D Rodrigues, et al.
Page
of 17